Exploris Health at the ESC Digital & AI Summit in Berlin
Originally published on explorishealth.com
We were thrilled to attend the ESC Digital & AI Summit 2025 on November 21–22 in Berlin. We’ve just wrapped up two inspiring days filled with innovation, valuable discussions, and powerful insights into the future of cardiovascular diagnostics.
Highlights from the ESC Digital & AI Summit 2025 in Berlin
Our contributions at the Summit
At booth E2 in Hall B01, we demonstrated how Exploris Health is advancing cardiovascular care with the AI-powered Cardio Explorer®—and had the opportunity to engage in numerous discussions with interested doctors, researchers, and industry experts.
A key highlight was our Industry Symposium:
"From Arteries to Algorithms: Foundational Models for Coronary Artery Disease Diagnosis and Cardiovascular Risk Assessment," which took place on Saturday, November 22, at 10:55 a.m. on the Digital Stage.
In this session, we explained how foundation models can overcome the limitations of traditional risk factor-based approaches—enabling more efficient, accurate, and scalable diagnostics for coronary artery disease (CAD) across different patient groups.
New clinical findings were presented
We presented new data from the recently published post-hoc analysis of our clinical trial (Remppis et al., 2025), including:
🔹 Highest discriminative ability in low- and high-prevalence cohorts (AUC 0.878 / 0.868) 🔹 Reliable rule-out performance at 5% and 15% thresholds (NPV >95%) 🔹 More precise risk stratification compared to established ESC scores
These results highlight the strong potential of foundation models to support earlier and more reliable assessment of coronary artery disease.
Poster presentation
Alexander Büsser also presented our latest research findings on the MPA_v3 model during his own poster session.
Our entire industry session is available online at this link: https://youtu.be/rXcPxUc0nug
Are you interested in how Cardio Explorer® applies to your coronary pathway? Our team would be happy to walk you through the platform and the evidence behind it.
